T he c-myc protooncogene plays a critical role in cellular proliferation. Its deregulated expression leads to the development of cancer and homozygous deletion of c-myc in Rat1 fibroblasts leads to significant lengthening of the cell cycle (1) . It has been demonstrated that ectopic expression of c-Myc promotes cell-cycle progression and shortens G 1 phase in cycling cells (2, 3) . The mechanism(s) by which c-Myc regulates the cell cycle is not fully understood, although c-Myc has been found to transactivate and transrepress several cell-cycle-regulatory genes (4) (5) (6) (7) (8) (9) (10) .
Transforming growth factor ␤ (TGF␤) treatment leads to G 1 cell-cycle arrest of several cell types, including epithelial, endothelial, and hematopoietic cells. Loss of TGF␤ responsiveness occurs in several types of cancer. This loss of responsiveness is typically the result of loss of TGF␤ receptor expression or defects in downstream signaling events controlled by TGF␤ (11) (12) (13) (14) (15) . Inhibition of the cell cycle by TGF␤ is thought to be mediated in part by down-regulation of proliferative proteins, such as c-myc, coupled with up-regulation of cell-cycle-inhibitory proteins, such as p15 INK4b , p21 CIP1 , or p27 KIP . Regulation of these genes by TGF␤ signaling occurs at transcriptional and posttranslational levels (13, 16) .
Increased expression of p21
CIP1
is associated with cell-cycle inhibition, differentiation, and cellular senescence (17) (18) (19) . The p21 CIP1 protein is a member of a group of cell-cycle-inhibitory proteins including p27 KIP1 and p57 KIP2 . These proteins function by associating with cyclin͞cdk complexes to inhibit their activity. p21 CIP1 transcription is regulated by several factors, including p53, C͞EBP ␣ and ␤, and E1A (20) (21) (22) (23) . Interestingly, p21 CIP1 transcription is stimulated by cycloheximide treatment (24) , implying transcription may be repressed by a protein factor with a short turnover rate.
It has been shown previously that ectopic expression of c-Myc will inhibit the action of TGF␤ on the cell cycle in BALB͞MK murine keratinocytes, M1 murine myeloid leukemia cells, and CCL64 mink-lung epithelial cells (25) (26) (27) . We demonstrate here that ectopic expression of c-Myc also inhibited TGF␤-mediated repression of cell-cycle progression in human immortalized keratinocytes promoter repressed by c-Myc does not overlap with the TGF␤-responsive element or other previously identified regulatory regions but is in close proximity to the site of transcriptional initiation.
Materials and Methods
Antibodies and Reagents. Generation and purification of anti-Mycfl and anti-av-Myc 12C antibodies have been described previously (28, 29) . Recombinant human TGF␤1 was purchased from R & D Systems. Puromycin and hygromycin B were purchased from Calbiochem. Trichostatin A (TSA) was purchased from Sigma.
Plasmids.
A vector encoding the murine ecotropic virus receptor (hygro muEcoR) was obtained from Scott Lowe (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). Construction of CMV-Myc2 and pBABE-Myc2 has been previously described (30, 31) . The murine c-Myc cDNA used in these constructs has a mutation at the CUG upstream initiation site to prevent synthesis of the c-Myc-1 protein (30) . In addition, the murine penultimate carboxyl-terminal glycine was mutated to arginine so that the avian-specific antiserum (anti-av-myc 12C) can selectively immunoprecipitate the exogenous murine protein (31) . A reporter vector containing a 2.3-kb fragment of the p21 CIP1 promoter was obtained from Rebecca Chinery (Mayo Clinic) and has been described previously (22, 32) . The p21 CIP1 promoter deletion luciferase vectors p21P Sma, p21P Sma⌬1, and p21P Sma⌬2 were obtained from Xiao-Fan Wang (Duke University, Durham, NC) and have been described previously (33) . The gadd45 reporter vector was obtained from Linda Penn (University of Toronto) and has been described previously (34) . The human matrilysin promoter reporter vector was obtained from Howard Crawford (Vanderbilt University, Nashville, TN) and was made by subcloning a 2.3-kb Mfe I fragment of the human matrilysin promoter (35) into the EcoRI site of pGL2-Basic (Promega).
Transient Transfections. For transient transfection assays, NIH 3T3 cells were transfected by using LipofectAmine (GIBCO͞BRL) in serum-free media for 6 hr, then media were replaced with DMEM with 10% CS. Cells were harvested 48 hr after transfection. Relative levels of p21 CIP1 mRNA were normalized to cyclophilin levels, and levels of p21 CIP1 in vector-only-transfected cells were set to a value of one for comparison.
Generation of Stable Cell Lines.
HaCaT cells were maintained in DMEM with 10% FBS. To facilitate the infection of these human cells with an ecotropic murine retrovirus, HaCaTs were first stably infected with hygro muEcoR. Cells were selected with hygromycin at 500 g͞ml for approximately 7 days. Cells were then infected with viral supernatants containing pBABE empty vector or pB-ABE-Myc2 collected from 2 packaging cell lines. Cells were selected with puromycin at 1 g͞ml for approximately 3 days, and clonal cell lines were isolated.
For stable luciferase reporter cell lines, transfections were performed as described above. NIH 3T3 cells were cotransfected with full-length p21 CIP1 promoter luciferase construct and empty pBABE-hygro. Cells were selected for 2 days with 500 g͞ml hygromycin B, then several clones were isolated. Individual clones were analyzed for basal luciferase activity, and four independent clones were subsequently infected with either empty pBABE-puro vector or a c-Myc2 expression vector. Cells were selected in 1 g͞ml puromycin for 2 more days and luciferase activity determined.
RNA Isolation and Northern Analysis. Total RNA was isolated by using Trizol (GIBCO͞BRL). Total RNA was then subjected to polyAϩ selection with oligo dT cellulose (ICN). Approximately 2 g polyAϩ mRNA was separated on 1% agarose-5.4% formaldehyde denaturing gels and transferred. Blots were then UV crosslinked and prehybridized for 30 minutes with ExpressHyb (CLONTECH). Hybridization of probe was performed at 68°C for 1 hr with ExpressHyb. Probes were labeled with [␣-32 P]-dCTP (ICN) with the PrimeIt II random labeling kit (Stratagene). Blots were probed sequentially without stripping for p21 CIP1 and cyclophilin. Northern blots for all HaCaT samples were probed with human p21 CIP1 probe, whereas samples from NIH 3T3 cells were probed with murine p21 CIP1 probe.
Western Blot Analysis. Cells were lysed in RIPA buffer (1X PBS͞1% Triton-X 100͞0.5% sodium deoxycholate͞0.1% SDS͞30 g͞ml aprotinin͞10 g͞ml PMSF) and sonicated briefly. Samples were normalized by standard protein assay (Bio-Rad), separated by SDS͞PAGE and transferred to nitrocellulose (Schleicher & Schuell). Blots were probed overnight with the indicated primary antibodies and incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Jackson Laboratory) in 3% milk͞TBS (20 mM Tris, pH 7.6͞137 mM NaCl) buffer. Blots were washed with TBS.
Reporter Assays. NIH 3T3 cells were plated at 5 ϫ 10 5 cells͞60-mm dishes and transfected 24 hr later, as described above. Cells were cotransfected with p21 CIP1 luciferase vector, SV40-␤-galactosidase (␤-gal) and either empty CMV or CMV-Myc2. Cells were harvested 48 hr after transfection and lysed in Reporter Lysis Buffer (Promega). Luciferase activity was normalized by ␤-gal activity. Fold activity was then determined compared to empty vector control. Ectopic protein expression was confirmed by Western blot analysis to verify comparable expression (data not shown).
For stable NIH 3T3 p21 CIP1 reporter lines, clonal lines were plated in 24-well plates. Cells were harvested 24 hr later and lysed in Promega lysis buffer. Luciferase activity was normalized by protein assay. For TSA tests, four clonal lines were seeded in 24-well plates and left untreated or treated with TSA at 500 ng͞ml for 24 hr. Cells were then lysed in Reporter Lysis Buffer (Promega). Luciferase activity was normalized by standard protein assay (BioRad). To determine the effects of TSA on p21 CIP1 promoter activity, fold activity was determined by comparing luciferase activity of samples to that of untreated vector only control.
Results

Up-Regulation of p21 CIP1 Correlates with Down-Regulation of c-Myc
Protein After TGF␤ Treatment of HaCaT Cells. We sought to examine the effect of TGF␤ activity on c-Myc and p21 CIP1 expression. In separate studies, it has been shown that TGF␤ treatment of epithelial cells leads to both up-regulation of p21 CIP1 transcription and down-regulation of c-Myc (36) (37) (38) (39) (40) . However, a temporal correlation between these events has not been demonstrated. To determine whether these events are related, we treated HaCaTs with TGF␤ for the time periods indicated in Fig. 1 . Western blot analysis revealed a rapid decrease in c-Myc proteins levels ( Fig. 1 A  Upper) . Down-regulation of c-Myc mRNA was confirmed by Northern blot analysis (data not shown). This down-regulation was paralleled by an up-regulation of p21 CIP1 mRNA, as shown by Northern blot analysis ( Fig. 1 A Lower) . Rapid increase of p21 CIP1 mRNA expression occurred immediately after the rapid downregulation of c-Myc protein, indicating that these events may be interdependent (Fig. 1B) . down-regulation of c-Myc protein (Fig. 2B ). This stable expression of c-Myc protein resulted in an inhibition of TGF␤-mediated repression of DNA synthesis as determined by [ 3 H]thymidine incorporation (Fig. 2C ). This degree of inhibition of TGF␤ activity by ectopic c-Myc expression is similar to that found in other cell lines (25) . Therefore, enforced expression of c-Myc is capable of attenuating TGF␤ activity in HaCaT cells.
Because c-Myc protein levels and p21 CIP1 mRNA levels exhibited an inverse relationship after TGF␤ treatment, we examined the expression of p21 CIP1 in these clonal HaCaT lines stably expressing c-Myc. As shown in Fig. 2D , Northern blot analysis of vectorcontaining HaCaT lines demonstrated a dramatic up-regulation of p21 CIP1 mRNA after TGF␤ treatment. However, up-regulation of p21 CIP1 message was effectively blocked in HaCaT lines ectopically expressing c-Myc (Fig. 2D) . Thus, the block of TGF␤ inhibition of cell-cycle progression may be because of repression of p21 CIP1 transcription by c-Myc. mRNA. NIH 3T3 cells were plated at high density (confluent at harvest) and lower density (subconfluent at harvest) and transfected with either vector only or c-Myc expression vector. Cells transfected with c-Myc exhibited high levels of c-Myc protein as compared to endogenous protein levels in vector-only transfected cells, as determined by Western blot analysis (data not shown). Northern blot analysis showed that p21 CIP1 mRNA levels were unchanged in confluent cells (Fig. 3A) but diminished in subconfluent cells transfected with c-Myc (Fig. 3B) . Densitometric analysis normalized to cyclophilin-loading control demonstrated that p21 CIP1 levels were decreased approximately 50% in subconfluent c-Myc-transfected cells (Fig. 3 Bottom) . Thus, overexpression of c-Myc can repress transcription of p21 CIP1 , although this effect depends on the density of the cells in culture. reporter constructs have been used previously to identify major regulatory regions within this promoter (22, 23, 32, (41) (42) (43) . After a short selection period, several clones were isolated and analyzed for luciferase activity. Four independent clones with varying levels of basal luciferase activity were subsequently infected with either empty vector or c-Myc expression vector. We found that c-Myc-repressed luciferase activity driven by the p21 CIP1 promoter in all four lines by an average of 0.68-fold (Fig. 4A) .
To verify this repression by another method, we demonstrated further repression of the p21 CIP1 promoter in NIH 3T3 cells by transient transfection. Transient transfection of c-Myc expression vector with this reporter construct in NIH 3T3 cells revealed that c-Myc repressed transcription from the p21 CIP1 promoter by reporter assay an average of 0.44-fold (Fig. 4B) . Transient transfection may result in slightly increased repression of the p21 CIP1 promoter as compared to stable transfection, because expression levels of c-Myc are higher after transient transfection (data not shown). To compare the degree of repression of the p21 CIP1 promoter by c-Myc to that of another c-Myc-repressed promoter, repression of the gadd45 promoter was analyzed. The fold repression of the gadd45 promoter in transient transfection assays (0.54 average fold) was found to be similar to that for the p21 CIP1 promoter ( Fig. 4C ; compare to Fig. 4B ). As a negative control, we examined a luciferase construct containing the human matrilysin promoter, which has not been shown to be regulated by c-Myc. The matrilysim promoter was not found to be affected by c-Myc expression (Fig.  4D) . Similar results were found in transient transfections using a promoterless pGL2-Basic luciferase vector, demonstrating that c-Myc expression also does not affect basal luciferase expression or activity (data not shown). Therefore, the repression of the p21 CIP1 promoter by c-Myc is specific.
Repression by c-Myc Does Not Involve Histone Deacetylase Activity.
One mechanism of transcriptional repression involves recruitment of histone deacetylase to a promoter. Deacetylation of histones is believed to prevent disassembly of nucleosomes, which results in DNA remaining inaccessible to transcriptional activation. To test this mechanism of repression, we treated four of the stable p21 CIP1 -reporter lines described above with TSA, an inhibitor of histone deacetylase activity. It has been demonstrated previously that TSA treatment activates transcription from the p21 CIP1 promoter (42) . TSA treatment of the p21 CIP1 luciferase stable lines did result in up-regulation of luciferase activity in control lines containing empty retroviral vector only, where fold activity of TSA-treated cells was compared to untreated cells (Fig. 5A) . Stable p21 CIP1 reporter cell lines coinfected with either empty retroviral vector or c-Myc expression vector were then analyzed after TSA treatment. In this experiment, fold luciferase activity was calculated as compared to luciferase activity of untreated vector only cells (Fig. 5B) . Although fold luciferase activity of TSA-treated c-Myc expressing cells was increased to approximately 1.8-fold, correspondingly the fold activity of vector-only control cells increased to 2.9-fold after TSA treatment. Thus, the relative fold activity of TSA-treated c-Myc expressing cells as compared to TSA-treated vector-only control cells was approximately 0.60-fold activity. This fold repression of luciferase activity of the p21 CIP1 promoter is similar to that of untreated c-Myc expressing cells compared to vector-only controls (0.67-fold; Fig. 5B ). Therefore, we conclude from this experiment that TSA treatment did not significantly affect repression of the p21 CIP1 promoter by c-Myc, and that histone deacetylase activity is not required for Myc-mediated repression of p21 CIP1 . after TGF␤ treatment (33) . The specific deletion constructs are represented in Fig. 6B . As shown in the top diagram of Fig. 6B , the construct p21P Sma removes binding sites for p53 as well as C͞EBP ␣ and ␤. The deletion construct p21P Sma ⌬1 further removes the TGF␤-responsive element (Ϫ86 to Ϫ71) and comes within approximately 20 nucleotides 5Ј of the TATA box (black bar in diagrams). This element is then specifically removed in the deletion p21P Sma⌬2 (Fig. 6B Bottom) . The full-length p21 CIP1 promoter or the various deletion luciferase constructs were transiently transfected into cells and cotransfected with either empty CMV vector or CMV-Myc2. Repression of the p21 CIP1 promoter by c-Myc was not significantly affected by deletion of p53 or C͞EBP-binding sites (p21P Sma) (Fig. 6C) . Further removal of the TGF␤-responsive element (p21P Sma⌬1) also did not affect repression by c-Myc. Finally, c-Myc-mediated repression of the p21 CIP1 promoter was not affected by specific removal of the TGF␤-responsive element (p21P Sma⌬2). These results indicate that c-Myc repression does not overlap with the TGF␤-responsive element or the binding sites for p53 or C͞EBP proteins, but appears to act through a region between Ϫ62 bp and ϩ16 bp of the start site of transcription.
Discussion
In this paper, we have examined the role of Myc-mediated repression of p21 CIP1 in TGF␤-mediated growth arrest. Enforced c-Myc expression has been shown previously to abrogate TGF␤-mediated cell cycle inhibition in murine keratinocytes (Balb͞MK), murine myeloid leukemia cells (M1), and mink-lung epithelial cells (CCL64) (25) (26) (27) . Here, we have extended these observations to include the immortalized HaCaT cell line. Furthermore, we demonstrated that c-Myc blocked up-regulation of p21 CIP1 mRNA in TGF␤-treated cells. We also presented evidence that overexpression of c-Myc in subconfluent murine NIH 3T3 fibroblasts resulted in repressed levels of p21 CIP1 mRNA. In support of these observations, we also have found that p21 is an important event in Myc-dependent cell-cycle progression. Our results demonstrating that repression of p21 CIP1 transcription by c-Myc is associated with cell-cycle promotion provide further insight into the pathways by which c-Myc regulates cell-cycle progression. p21 CIP1 expression is highly regulated by a variety of factors that either activate or repress transcription. This regulation of p21 CIP1 levels in the cell is critical for the functional effects of p21 CIP1 expression, because it has been shown that at low levels, p21 CIP1 may serve as a scaffold for active cyclin͞cdk complexes, whereas higher levels of p21 CIP1 inhibit cyclin͞cdk activity (47) (48) (49) . Thus, the balance of factors regulating p21 some insight into regulation of p21 CIP1 levels in the absence and presence of c-Myc, we have examined quiescent and serumrestimulated HaCaT cells and human foreskin fibroblasts. An inverse relationship exists between c-Myc and p21 CIP1 expression as cells become growth inhibited after serum deprivation and during subsequent restimulation (unpublished observations).
The recent development of c-Myc-null Rat1 fibroblasts provides a system in which to examine gene expression in the absence of c-Myc (50) . Analysis of expression of putative c-Myc-regulated genes in this cell line revealed that several genes previously reported to be activated by c-Myc do not exhibit significant alterations in expression, with the exception of cad (51) . However, autorepression of the c-Myc promoter as well as repression of gadd45 was shown to be altered in the c-Myc null fibroblasts as compared to either the wild-type c-Myc parental Rat1 cell line or cells in which c-Myc expression was restored (51) . We attempted to analyze p21 CIP1 expression in these cells; however, we were unable to detect p21 CIP1 (unpublished observations). Similarly, other groups have been unable to detect p21 CIP1 in Rat1 fibroblasts (52) (53) . Although it was found that p21 CIP1 protein levels appear to be diminished in the c-Myc-null Rat1 cells (54) , other recent reports support repression of p21 CIP1 by c-Myc (46, 55) .
Repression of p21 CIP1 at the Promoter Level. In this report, we demonstrate that c-Myc transcriptionally represses the p21 CIP1 promoter. Furthermore, we localized the region of this repression within approximately 60 nucleotides upstream of the start site of transcription. Any further deletions would most likely impact on basal transcription, because the TATA box is located at Ϫ47 bases relative to the transcription start site. This region does not overlap with previously identified regions of regulation by factors such as p53 or C͞EBP proteins (56) . The finding that HaCaT cells have two mutant alleles for p53 (39) supports our data, demonstrating that repression of the p21 CIP1 promoter is independent of the p53-binding site. Finally, we demonstrated that deletion of the region associated with up-regulation after TGF␤ signaling also does not affect repression of this promoter by c-Myc. Therefore, c-Myc repression of the p21 CIP1 promoter involves a mechanism independent of these regulatory regions.
Because c-Myc is capable of repression of the p21 CIP1 promoter through a region immediately upstream of the transcriptional start site, we tested whether repression involved histone deacetylase activity. Histone deacetylase is recruited to promoters by many transcriptional repressors, including Mad proteins, which compete with c-Myc for binding to Max (57) (58) (59) . Also, it has been shown that transcription from the p21 CIP1 promoter is activated after treatment with TSA, a histone deacetylase inhibitor (42) . We utilized cell lines stably transfected with a p21 CIP1 promoter reporter vector, because chromatin assembly may not be complete in transient transfections.
Our results indicate that c-Myc represses p21 CIP1 transcription by a mechanism independent of histone deacetylase activity.
With the exception of C͞EBP-binding sites, the p21 CIP1 promoter lacks other known Myc-binding sequences, including E-box Myc sequences (EMS) and Inr elements (60, 61) . Similarly, the gadd45 promoter, which is also repressed by c-Myc, also lacks EMS or Inr sequences. However, repression of these genes by c-Myc may not involve direct DNA binding. c-Myc may repress gene transcription by binding directly to transcriptional components and preventing formation of an active preinitiation complex. Alternatively, c-Myc may bind the preinitiation complex and prevent transcriptional initiation. Indeed, it has been shown that c-Myc binds TATA box-binding protein, a key component of the basal transcriptional machinery (62, 63) . Further investigation is necessary to clarify the mechanisms by which c-Myc mediates gene repression.
